A new study reveals that many perceived benefits of gluten-free products, such as weight control and diabetes management, are ...

Hormone diets have taken off on social media as the latest weight loss trend, but their scientific validity remains ...

Pfizer has made the decision to discontinue the clinical development program for danuglipron, an oral GLP-1 receptor agonist, being investigated for chronic weight management.

The prevalence of irritable bowel syndrome and chronic idiopathic constipation rose significantly during the COVID-19 pandemic.

Incidental BE was common and associated with high-risk features that were similar to or more severe than those found in BE diagnosed by traditional methods.

Thanks for visiting Gastroenterology Advisor. We hope you’re enjoying the latest clinical news, full-length features, case studies, and more. You’ve view ...

PBGENE-HBV is designed to potentially cure chronic hepatitis B by eliminating the root cause of the virus. The Food and Drug Administration (FDA) has granted Fast Track designation to PBGENE-HBV, an ...

HealthDay News — The viability of hospital-based emergency care in the United States is at risk, according to a RAND report released April 7.

A federal team responsible for setting poverty guidelines that determine who qualifies for health and food assistance has been fired.

Key labs at the US CDC have shut down amid recent layoffs, raising concerns about tracking and controlling serious infections.

Patients with eosinophilic esophagitis who had an Index of Severity score of 15 or higher responded less favorably to topical corticosteroids, with lower rates of histologic remission, less symptom ...